Clinical Trials Browser

Recruiting × Observational × Rituximab × Clear all

NCT07233720 2025-11-18

Zanubrutinib Combined With Rituximab in the Treatment for Patients With Marginal Zone Lymphoma

Lymphoma, B-Cell, Marginal Zone